Compound Monograph

Verbascoside

Phenolics Phenylpropanoids Natural (plant-derived)

Verbascoside (acteoside) is a caffeoyl phenylethanoid glycoside — one of the most widespread and most-studied plant phenolics, with broad antioxidant and anti-inflammatory activity in vitro. Its defining limitation is bioavailability: absolute oral bioavailability is roughly 0.12% in rats because gut bacteria hydrolyze it before absorption, so nearly every isolated-molecule finding is in vitro or preclinical and there is no isolated-molecule human trial.

Sources · 14

Where Does It Come From?

Verbascoside is a naturally occurring phenylethanoid glycoside, found in Mullein, Olive, Rehmannia and 11 other sources. It is well tolerated orally (low toxicity).

Also found in
Cistanche Monograph coming soon
Lemon verbena Monograph coming soon
Olive Monograph coming soon

Concentration

Content by Source

Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.

Verbascoside at a Glance

Verbascoside (acteoside) is a caffeoyl phenylethanoid glycoside and one of the most widespread and most-studied plant phenolics, present in mullein, olive leaf, plantain, lemon verbena and many others.

It has broad antioxidant and anti-inflammatory activity in vitro — and its defining limitation is bioavailability: verbascoside is poorly absorbed and extensively degraded by gut bacteria, so very little reaches circulation intact, which stands between its large laboratory record and any human claim.

What It's Used For

Verbascoside — more often called acteoside in the pharmacology literature — is a caffeoyl phenylethanoid glycoside: a caffeic-acid ester linked through a rhamnose–glucose sugar to a hydroxytyrosol (dihydroxyphenylethanol) unit. It is one of the most widespread phenolics in the plant kingdom, and here it turns up across unrelated families — mullein, rehmannia, catnip, dagga, warrior’s plume and pau d’arco — as one of the more abundant single constituents. Its two catechol (dihydroxyphenyl) groups make it a powerful radical scavenger and metal chelator, and isolated verbascoside shows anti-inflammatory, neuroprotective, anti-fatigue and cytostatic activity across cell and rodent models 1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →2Reference 2Alipieva K et al. · 2014ReviewVerbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — reviewView study →.

The caveat runs through all of it and reframes everything else: verbascoside’s absolute oral bioavailability is roughly 0.12% in rats because intestinal bacteria hydrolyze the glycoside before it can be absorbed 1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →.

Intact verbascoside barely reaches the circulation, so a potent in-vitro concentration is not something an oral dose reaches systemically, and no effect here has been tested as the isolated molecule in a human trial.

Best-supported:Anti-inflammatory activity — isolated verbascoside suppresses iNOS/NF-κB signaling and lowers nitric oxide in human THP-1 monocytes 3Reference 3Speranza L et al. · 2010In vitroAntiinflammatory effects in THP-1 cells treated with verbascoside — in vitro (human monocytes)View study →, directly inhibits the phosphatase calcineurin 4Reference 4Prescott TAK et al. · 2011In vitroDirect inhibition of calcineurin by caffeoyl phenylethanoid glycosides from Teucrium chamaedrys and Nepeta cataria — in vitro / enzyme assayView study →, and the phenolic fraction binds the COX-2 catalytic site 5Reference 5Ma S et al. · 2017In vitroTaheebo Polyphenols Attenuate Free Fatty Acid-Induced Inflammation in Murine and Human Macrophage Cell Lines As Inhibitor of Cyclooxygenase-2 — in vitroView study →. The mechanisms are unusually well resolved for a plant phenol.
Emerging, worth watching:Neuroprotection / antidepressant effects, where an oral rodent study locates the action in the gut-microbiota–brain axis 6Reference 6Mao Q et al. · 2024AnimalCo-decoction of Lilii bulbus and Radix Rehmannia Recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis — mouse modelView study → — a mechanism that is coherent despite poor systemic absorption. Also strong cell-free antioxidant/chelating activity 7Reference 7Wang P et al. · 1996In vitroScavenging effects of phenylpropanoid glycosides from Pedicularis on superoxide anion and hydroxyl radical by the spin trapping method — in vitroView study →8Reference 8Li J et al. · 1997In vitroAntioxidative and chelating activities of phenylpropanoid glycosides from Pedicularis striata — in vitroView study →.
Mechanistically thin / niche:Anti-fatigue signals from a few rodent and in-vitro studies 9Reference 9Liao F et al. · 1999In vitroRetardation of skeletal muscle fatigue by the two phenylpropanoid glycosides verbascoside and martynoside from Pedicularis plicata — in vitroView study →10Reference 10Zhu M et al. · 2016AnimalCentral anti-fatigue activity of verbascoside — rodent in vivo animal modelView study →, and single-cell-line anticancer data (telomerase inhibition, G2/M arrest) 11Reference 11Zhang F et al. · 2002In vitroIn vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside — in vitroView study →.
The caveat:~0.12% oral bioavailability with extensive gut-bacterial hydrolysis 1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →; every finding is in vitro or preclinical; there is no isolated-verbascoside human trial.
Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume, tempered for isolate-vs-plant match and bioavailability. A beta, not a validated metric. Each application links to its write-up.

Mechanisms

Target / pathwayEffectRelevant to
NF-κB / iNOSSuppresses → ↓nitric oxide, ↓pro-inflammatory cytokines
Anti-inflammatory
CalcineurinDirectly inhibits (Ca²⁺/calmodulin phosphatase) → ↓T-cell activation
Anti-inflammatory / immune
COX-2Binds catalytic site → ↓prostaglandins (in polyphenol mixture)
Anti-inflammatory
Superoxide / hydroxyl radicals, Fe²⁺Scavenges / chelates (catechol groups)
Antioxidant
Gut microbiota–brain axisRestores intestinal barrier, ↓neuroinflammation
Neuroprotection
Central 5-HTLowers exercise-induced central serotonin
Anti-fatigue
Telomerase, cell cycle (G2/M)Inhibits / arrests
Anticancer

Pharmacokinetics

Bioavailability is the load-bearing fact for the entire verbascoside literature. After oral dosing in rats the absolute oral bioavailability is only about 0.12%: the compound is absorbed and cleared quickly (peak plasma concentration within roughly 15 minutes), binds plasma protein at ~75%, and — critically — is extensively hydrolyzed by intestinal bacteria before absorption, cleaving to its building blocks hydroxytyrosol and caffeic acid plus further degradation products 1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →. This means the intact glycoside barely reaches the systemic circulation, and much of any oral effect is more plausibly attributable to its gut metabolites or to luminal/gut-axis action than to circulating verbascoside — which is exactly why the coherent in-vivo signal here (the antidepressant work) is framed through the gut-microbiota–brain axis 6Reference 6Mao Q et al. · 2024AnimalCo-decoction of Lilii bulbus and Radix Rehmannia Recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis — mouse modelView study →. On the interaction side the news is reassuring: in human in-vitro systems verbascoside showed only weak inhibition of CYP1A2 and CYP1B1 (IC₅₀ ~83–86 µM), no CYP-mediated oxidative metabolism, and instead extensive Phase-II conjugation (methylation and sulfation), leading the authors to conclude it has no clinically relevant CYP-mediated interaction potential 12Reference 12Reid AM et al. · 2019In vitroIn Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes — in vitroView study →. The practical upshot: potent in-vitro concentrations are not trivially reachable from an oral dose, which tempers every downstream claim.

Clinical trials

There are essentially no registered trials of isolated verbascoside; human exposure is limited to verbascoside-rich foods and extracts (olive leaf, Cistanche, the herbs above), which are plant-matrix exposures and cannot be read as a molecule result. Everything here is in vitro or preclinical.

CompletedPlannedTerminatedPreclinical
None(isolated verbascoside)None knownNoneExtensive

Last checked: July 2026.

Toxicity & Safety

Verbascoside carries a low toxicity flag. As a normal constituent of foods such as olives and olive leaf, and of many widely used herbs, it is regarded as having low toxicity at dietary levels, and reviews describe no signature acute organ toxicity in the animal studies performed with it 1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →. Its interaction profile is favorable rather than worrying: in human in-vitro systems it inhibits CYP enzymes only weakly (CYP1A2/CYP1B1, high-micromolar IC₅₀), is not oxidatively metabolized by CYPs, and clears mainly through Phase-II conjugation, so it is judged to have no clinically relevant CYP-mediated drug-interaction potential 12Reference 12Reid AM et al. · 2019In vitroIn Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes — in vitroView study →. The one direct developmental-toxicity datapoint here is at the whole-extract level, not the isolated molecule: a Leonotis nepetifolia flower extract (which contains verbascoside among many constituents) was assessed for toxicity in zebrafish embryos 13Reference 13Adolpho L et al. · 2026Comprehensive analysis of Leonotis nepetifolia flower extracts: phytochemical composition and toxicity in zebrafish embryos — phytochemical / zebrafish embryoView study → — a whole-plant result that cannot be read as a verbascoside finding. No dedicated human safety database exists for isolated, high-dose verbascoside, so absence of reported harm should not be read as established safety at supra-dietary doses.

Dosage

There is no established human dose for isolated verbascoside, and its poor oral bioavailability makes any extrapolation speculative. Preclinical work spans a wide range: rodent studies commonly use oral doses in the tens of milligrams per kilogram, and in-vitro effects appear at low-to-mid micromolar concentrations (e.g. muscle-fatigue retardation at 20 µM 9Reference 9Liao F et al. · 1999In vitroRetardation of skeletal muscle fatigue by the two phenylpropanoid glycosides verbascoside and martynoside from Pedicularis plicata — in vitroView study →, gastric-cell cytostasis around 17.8 µg/mL 11Reference 11Zhang F et al. · 2002In vitroIn vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside — in vitroView study →) — figures that the ~0.12% oral bioavailability 1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study → makes hard to reach in a living animal from an oral dose. These are doses studied in research and are not a personal recommendation.

References

  1. Xiao Y, et al. (2022). The pharmacokinetic property and pharmacological activity of acteoside: A review — review. Biomedicine & Pharmacotherapy. https://pubmed.ncbi.nlm.nih.gov/35724511/
  2. Alipieva K, et al. (2014). Verbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — review. Biotechnology Advances. https://pubmed.ncbi.nlm.nih.gov/25048704/
  3. Speranza L, et al. (2010). Antiinflammatory effects in THP-1 cells treated with verbascoside — in vitro (human monocytes). Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/20812283/
  4. Prescott TAK, et al. (2011). Direct inhibition of calcineurin by caffeoyl phenylethanoid glycosides from Teucrium chamaedrys and Nepeta cataria — in vitro / enzyme assay. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/21843624/
  5. Ma S, et al. (2017). Taheebo Polyphenols Attenuate Free Fatty Acid-Induced Inflammation in Murine and Human Macrophage Cell Lines As Inhibitor of Cyclooxygenase-2 — in vitro. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/29312947/
  6. Mao Q, et al. (2024). Co-decoction of Lilii bulbus and Radix Rehmannia Recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis — mouse model. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/38696921/
  7. Wang P, et al. (1996). Scavenging effects of phenylpropanoid glycosides from Pedicularis on superoxide anion and hydroxyl radical by the spin trapping method — in vitro. Biochemical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/8615906/
  8. Li J, et al. (1997). Antioxidative and chelating activities of phenylpropanoid glycosides from Pedicularis striata — in vitro. Acta Pharmacologica Sinica (Zhongguo Yao Li Xue Bao). https://pubmed.ncbi.nlm.nih.gov/10072901/
  9. Liao F, et al. (1999). Retardation of skeletal muscle fatigue by the two phenylpropanoid glycosides verbascoside and martynoside from Pedicularis plicata — in vitro. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/10548760/
  10. Zhu M, et al. (2016). Central anti-fatigue activity of verbascoside — rodent in vivo animal model. Neuroscience Letters. https://pubmed.ncbi.nlm.nih.gov/26827721/
  11. Zhang F, et al. (2002). In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside — in vitro. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/11859459/
  12. Reid AM, et al. (2019). In Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes — in vitro. Molecules. https://pubmed.ncbi.nlm.nih.gov/31212689/
  13. Adolpho L, et al. (2026). Comprehensive analysis of Leonotis nepetifolia flower extracts: phytochemical composition and toxicity in zebrafish embryos — phytochemical / zebrafish embryo. Natural Product Research. https://pubmed.ncbi.nlm.nih.gov/39878299/